1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clinic. 2018;68:394–424.
2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584–94.
3. Wu C, Xu B, Zhou Y, Ji M, Zhang D, Jiang J, et al. Correlation between serum IL-1beta and miR-144-3p as well as their prognostic values in LUAD and LUSC patients. Oncotarget 2016;7:85876–87.
4. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA: Cancer J Clinic. 2017;67:7–30.
5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: Cancer J Clinic. 2016;66:7–30.